Grifols SA (GRFS)
7.83
-0.04
(-0.51%)
USD |
NASDAQ |
May 19, 16:00
7.83
0.00 (0.00%)
After-Hours: 17:16
Grifols Research and Development Expense (Quarterly) : 105.29M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cellectis SA | 23.09M |
| Biodexa Pharmaceuticals Plc | -- |
| Amarin Corp. Plc | 4.020M |
| Akari Therapeutics Plc | 1.084M |
| NuCana Plc | 4.329M |